Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) | Patent Publication Number 20210252017
US 20210252017 A1Patent NumberUS 11197869 B2
Application Number17233302
Filled DateApr 16, 2021
Priority DateMar 5, 2019
Publication DateAug 19, 2021
Original AssigneeWindtree Therapeutics Inc.
Current AssigneeWindtree Therapeutics Inc.
Inventor/ApplicantsPatrizia Ferrari
Mara Ferrandi
Paolo Barassi
Giuseppe Bianchi
Mara Ferrandi
Paolo Barassi
Giuseppe Bianchi
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.